Management of depression in the last month of life.
In clinical practice, assessment and adequate treatment of depression in the last month of life remain a difficult task. Although assessment instruments and criteria for depression are available for use in the palliative care population, few have been applied for the last weeks of life. The same is true for clinical management including antidepressants. Assessment aids such as Hospital Anxiety and Depression Scale or Hamilton Depression Rating Scale are available and validated for the last days or weeks of life, but its clinical impact remains unclear. The wish to die may symbolize more the acceptance that life comes to an end instead of reflecting a depressive or anxiety disorder. Communication about concrete preparation for death, life completion discussions, expressing religious struggle and giving back a sense of coherence seem to be promising non-pharmacological strategies and may lead to improved social function and better management of physical symptoms. Good news for researchers comes from a recent study highlighting the fact that psychosocial research seems to be of more potential benefit than burden for the patient. No recent literature can be found on the pharmacological management of depression in the last weeks of life. Few studies demonstrate the usefulness of concrete end of life preparation discussions that underpins the importance and impact of best carer-patient relationship during this last phase of life. A Cochrane protocol on antidepressants in severely physically ill patients has been undertaken recently to highlight this important clinical question, but results may reflect the lack of studies focusing on the last weeks or days of life.